Lexapro lawsuit filed against Forest Labs

Jul 26, 2006

A lawsuit has been filed against U.S.-based Forest Laboratories involving the deaths of two men taking the drug company's antidepressant, Lexapro.

The lawsuit was filed by Mark and Lucy Bibbee, who claim Lexapro caused both their sons -- their only children -- to commit suicide 17 months apart, the Akron (Ohio) Beacon Journal reported.

David Bibbee, 27, who suffered from bipolar disorder, took his own life Feb. 23, 2003, at his father's Stow, Ohio, home. Brian Bibbee, 24, who was receiving medical help for attention deficit disorder, died July 24, 2004, at his mother's Cuyahoga Falls, Ohio, home.

Both men were taking Lexapro, which has been linked with an increased risk of suicide.

The lawsuit claims Forest knew of the increased suicide risk, yet failed to conduct tests to see how often the problem developed and also failed to properly issue warnings, the Beacon Journal said.

Mark and Lucy Bibbee "believe this drug was the cause of both of their sons' deaths," attorney Charles Grisi told the newspaper. "They're pursuing this ... in hopes no other family will have to experience this tragedy."

Copyright 2006 by United Press International

Explore further: Treatment reduces symptoms in syndrome that causes extreme light sensitivity

Related Stories

Recommended for you

Should there be a dress code for doctors?

5 minutes ago

If you live near a hospital, you've probably seen the sight: a young physician in loose blue scrubs, standing in line at the grocery store. You can't help but wonder if the young physician is lost. After ...

Genome sequencing illuminates rare Aicardi syndrome

15 minutes ago

As my inbox fills with ever more updates on the number of human genomes sequenced and the plummeting time and cost of next next next generation sequencing, I find myself hitting delete more and more often. ...

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.